 |
인쇄하기
취소
|
Pfizer succeeds brand power through ‘Novasc V’
Pifzer Korea launches Exforge generic and joint-promotion with Novartis will be over soon
(Dailypharm)
Pfizer Korea launched ‘Novasc V,’ which is a combination drug of Amlodipine and Valsartan.
LG Life Sciences is accountable of supplying Novasc V to Pfizer Korea. But Novasc V is Novartis ‘Exforge’ generic, and Exforge is a product that is jointly-promoted by Pfizer and Novartis.
Pfiz...
(Dailypharm)
Pfizer Korea launched ‘Novasc V,’ which is a combination drug of Amlodipine and Valsartan.
LG Life Sciences is accountable of supplying Novasc V to Pfizer Korea. But Novasc V is Novartis ‘Exforge’ generic, and Exforge is a product that is jointly-promoted by Pfizer and Novartis.
Pfiz...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.